Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2023.04.043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Bingjie Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Diagnosis of acute graft-vs-host disease (aGVHD) based on clinical symptoms and biopsy of involved organ was not satisfactory; reliable plasma biomarkers or their panels would be of great value to increase the sensitivity and specificity for such a fatal complication. METHOD: One hundred two patients who received allogeneic hematopoietic stem cell transplantation in our center were included in this study. Systemic biomarkers of ST2, IP10, IL-2Rα, TNFR1, and organ-specific biomarkers of Elafin, REG-3α, and KRT-18F in plasma were tested by ELISA. The correlation of each biomarker or selected panel of some systemic and organ-specific biomarker with aGVHD was investigated. RESULTS: The level of each systemic biomarker in aGVHD patients was significantly higher than that in patients without aGVHD. Organ-specific biomarker of Elafin, REG-3α, and KRT-18F also had predictive value for aGVHD of skin, gastrointestinal tract, and liver, respectively. Combination of ST2 with one of the 3 organ-specific biomarkers could provide more accurate prediction for aGVHD with skin, gastrointestinal tract, and liver, respectively. CONCLUSIONS: All the biomarkers tested in our study correlated with the severity and clinical course of aGVHD. Combination of each systemic biomarker with organ-specific biomarker could increase the sensitivity and specificity for the diagnosis of aGVHD, whereas ST2 with organ-specific biomarker is more sensitive for the diagnosis of organ-specific aGVHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Peking University First Hospital, Beijing, China.
- Department of Hematology, Peking University First Hospital, Beijing, China. Electronic address: renhy0813@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, B., Yin, Y., Li, Y., Liang, Z., Liu, W., Sun, Y., Dong, Y., & Ren, H. (2023). Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.04.043
Vancouver
Wang B, Yin Y, Li Y, Liang Z, Liu W, Sun Y, et al. Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.04.043
BibTeX
@article{Wang2023,
author = {Wang, Bingjie and Yin, Yue and Li, Yuan and Liang, Zeyin and Liu, Wei and Sun, Yuhua and Dong, Yujun and Ren, Hanyun},
title = {Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2023.04.043}
}
EUVIMED